Inmed Pharmaceuticals Inc (INM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Operating Expenses | 1,934 | 1,564 | 1,559 | 2,204 | 2,507 |
| Operating Income | -1,934 | -1,564 | -1,559 | -2,204 | -2,507 |
| Interest Expense | 360 | 0 | 0 | 0 | 0 |
| Other Income | 51 | -35 | -58 | 180 | 13 |
| Pre-tax Income | -2,244 | -1,599 | -1,617 | -2,024 | -2,494 |
| Net Income Continuous | -2,244 | -1,599 | -1,617 | -2,024 | -2,494 |
| Net Income | $-2,244 | $-1,599 | $-1,617 | $-2,024 | $-2,494 |
| EPS Basic Total Ops | -185.00 | -155.00 | -150.00 | -195.00 | -240.00 |
| EPS Basic Continuous Ops | -184.19 | -153.15 | -154.76 | -193.84 | -238.81 |
| EPS Diluted Total Ops | -185.00 | -155.00 | -150.00 | -195.00 | -240.00 |
| EPS Diluted Continuous Ops | -184.19 | -153.15 | -154.76 | -193.84 | -238.81 |
| EBITDA(a) | $-1,898 | $-1,536 | $-1,532 | $-2,177 | $-2,479 |